Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-21,467
Closed -$384K 131
2019
Q4
$384K Sell
21,467
-24,415
-53% -$361K 0.02% 942
2019
Q3
$573K Buy
45,882
+13,900
+43% +$229K 0.03% 801
2019
Q2
$633K Buy
+31,982
New +$684K 0.04% 650
2019
Q1
Sell
-20,918
Closed -$427K 1305
2018
Q4
$427K Buy
20,918
+11,500
+122% +$360K 0.03% 791
2018
Q3
$347K Buy
+9,418
New +$411K 0.02% 988
2018
Q1
Sell
-58,215
Closed -$1.65M 1488
2017
Q4
$1.65M Buy
+58,215
New +$1.37M 0.07% 439

Other funds holding AXGN

A.R.T. Advisors's AXGN Position: Q1 2020 in Review

A.R.T. Advisors sold out of Axogen (AXGN) in Q1 2020, closing a stake of 21,467 shares — an estimated $384K sold.

A.R.T. Advisors first reported a position in AXGN in Q4 2017 and held it in 6 quarters. The position peaked at $1.65M in Q4 2017. 116 funds tracked by Wall St. Rank hold AXGN as of Q1 2020.

  • A.R.T. Advisors reported no remaining Axogen position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 21,467 Axogen shares in Q1 2020, an estimated $384K.
  • A.R.T. Advisors first reported a position in Axogen in Q4 2017 and held it in 6 quarters.
  • A.R.T. Advisors's Axogen position peaked at $1.65M in Q4 2017.
  • 116 funds tracked by Wall St. Rank held Axogen as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.